Neos Therapeutics Reports Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Neos Therapeutics (NEOS) PT Lowered to $10 at JMP Securities
November 12, 2018 7:40 AM ESTJMP Securities analyst Jason Butler lowered the price target on Neos Therapeutics (NASDAQ: NEOS) to $10.00 (from $22.00) while maintaining a Market Outperform rating. Neos reported 3Q18 earnings slightly below consensus estimates. Product sales were consistent with the preannouncement earlier this week and ~$2MM (15%) below consensus... More
